List of Tables
Table 1. Global Non-invasive Insulin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Non-invasive Insulin Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Non-invasive Insulin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Non-invasive Insulin Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Non-invasive Insulin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Non-invasive Insulin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Non-invasive Insulin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Non-invasive Insulin Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Non-invasive Insulin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Non-invasive Insulin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-invasive Insulin, Product Type & Application
Table 12. Global Key Manufacturers of Non-invasive Insulin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-invasive Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Insulin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-invasive Insulin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Non-invasive Insulin Sales by Region (2019-2024) & (K Units)
Table 18. Global Non-invasive Insulin Sales Market Share by Region (2019-2024)
Table 19. Global Non-invasive Insulin Sales by Region (2025-2030) & (K Units)
Table 20. Global Non-invasive Insulin Sales Market Share by Region (2025-2030)
Table 21. Global Non-invasive Insulin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Non-invasive Insulin Revenue Market Share by Region (2019-2024)
Table 23. Global Non-invasive Insulin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Non-invasive Insulin Revenue Market Share by Region (2025-2030)
Table 25. North America Non-invasive Insulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Non-invasive Insulin Sales by Country (2019-2024) & (K Units)
Table 27. North America Non-invasive Insulin Sales by Country (2025-2030) & (K Units)
Table 28. North America Non-invasive Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Non-invasive Insulin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Non-invasive Insulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Non-invasive Insulin Sales by Country (2019-2024) & (K Units)
Table 32. Europe Non-invasive Insulin Sales by Country (2025-2030) & (K Units)
Table 33. Europe Non-invasive Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Non-invasive Insulin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Non-invasive Insulin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Non-invasive Insulin Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Non-invasive Insulin Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Non-invasive Insulin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Non-invasive Insulin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Non-invasive Insulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Non-invasive Insulin Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Non-invasive Insulin Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Non-invasive Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Non-invasive Insulin Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Non-invasive Insulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Non-invasive Insulin Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Non-invasive Insulin Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Non-invasive Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Non-invasive Insulin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Non-invasive Insulin Sales (K Units) by Type (2019-2024)
Table 51. Global Non-invasive Insulin Sales (K Units) by Type (2025-2030)
Table 52. Global Non-invasive Insulin Sales Market Share by Type (2019-2024)
Table 53. Global Non-invasive Insulin Sales Market Share by Type (2025-2030)
Table 54. Global Non-invasive Insulin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Non-invasive Insulin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Non-invasive Insulin Revenue Market Share by Type (2019-2024)
Table 57. Global Non-invasive Insulin Revenue Market Share by Type (2025-2030)
Table 58. Global Non-invasive Insulin Price (US$/Unit) by Type (2019-2024)
Table 59. Global Non-invasive Insulin Price (US$/Unit) by Type (2025-2030)
Table 60. Global Non-invasive Insulin Sales (K Units) by Application (2019-2024)
Table 61. Global Non-invasive Insulin Sales (K Units) by Application (2025-2030)
Table 62. Global Non-invasive Insulin Sales Market Share by Application (2019-2024)
Table 63. Global Non-invasive Insulin Sales Market Share by Application (2025-2030)
Table 64. Global Non-invasive Insulin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Non-invasive Insulin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Non-invasive Insulin Revenue Market Share by Application (2019-2024)
Table 67. Global Non-invasive Insulin Revenue Market Share by Application (2025-2030)
Table 68. Global Non-invasive Insulin Price (US$/Unit) by Application (2019-2024)
Table 69. Global Non-invasive Insulin Price (US$/Unit) by Application (2025-2030)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Novo Nordisk Non-invasive Insulin Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sanofi Non-invasive Insulin Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Eli Lilly Company Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Eli Lilly Non-invasive Insulin Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. MannKind Corporation Company Information
Table 86. MannKind Corporation Description and Business Overview
Table 87. MannKind Corporation Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. MannKind Corporation Non-invasive Insulin Product
Table 89. MannKind Corporation Recent Developments/Updates
Table 90. Biocon Company Information
Table 91. Biocon Description and Business Overview
Table 92. Biocon Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Biocon Non-invasive Insulin Product
Table 94. Biocon Recent Developments/Updates
Table 95. Janssen Pharmaceuticals Company Information
Table 96. Janssen Pharmaceuticals Description and Business Overview
Table 97. Janssen Pharmaceuticals Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Janssen Pharmaceuticals Non-invasive Insulin Product
Table 99. Janssen Pharmaceuticals Recent Developments/Updates
Table 100. Adocia Company Information
Table 101. Adocia Description and Business Overview
Table 102. Adocia Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Adocia Non-invasive Insulin Product
Table 104. Adocia Recent Developments/Updates
Table 105. Oramed Pharmaceuticals Company Information
Table 106. Oramed Pharmaceuticals Description and Business Overview
Table 107. Oramed Pharmaceuticals Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Oramed Pharmaceuticals Non-invasive Insulin Product
Table 109. Oramed Pharmaceuticals Recent Developments/Updates
Table 110. Dance Biopharm Company Information
Table 111. Dance Biopharm Description and Business Overview
Table 112. Dance Biopharm Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Dance Biopharm Non-invasive Insulin Product
Table 114. Dance Biopharm Recent Developments/Updates
Table 115. Medtronic Company Information
Table 116. Medtronic Description and Business Overview
Table 117. Medtronic Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Medtronic Non-invasive Insulin Product
Table 119. Medtronic Recent Developments/Updates
Table 120. Verily Life Sciences Company Information
Table 121. Verily Life Sciences Description and Business Overview
Table 122. Verily Life Sciences Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Verily Life Sciences Non-invasive Insulin Product
Table 124. Verily Life Sciences Recent Developments/Updates
Table 125. Zafgen Company Information
Table 126. Zafgen Description and Business Overview
Table 127. Zafgen Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Zafgen Non-invasive Insulin Product
Table 129. Zafgen Recent Developments/Updates
Table 130. Senseonics Company Information
Table 131. Senseonics Description and Business Overview
Table 132. Senseonics Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Senseonics Non-invasive Insulin Product
Table 134. Senseonics Recent Developments/Updates
Table 135. Bigfoot Biomedical Company Information
Table 136. Bigfoot Biomedical Description and Business Overview
Table 137. Bigfoot Biomedical Non-invasive Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Bigfoot Biomedical Non-invasive Insulin Product
Table 139. Bigfoot Biomedical Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Non-invasive Insulin Distributors List
Table 143. Non-invasive Insulin Customers List
Table 144. Non-invasive Insulin Market Trends
Table 145. Non-invasive Insulin Market Drivers
Table 146. Non-invasive Insulin Market Challenges
Table 147. Non-invasive Insulin Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Non-invasive Insulin
Figure 2. Global Non-invasive Insulin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Non-invasive Insulin Market Share by Type: 2023 & 2030
Figure 4. Pills Product Picture
Figure 5. Sprays Product Picture
Figure 6. Others Product Picture
Figure 7. Global Non-invasive Insulin Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Non-invasive Insulin Market Share by Application: 2023 & 2030
Figure 9. Hospital Pharmacies
Figure 10. Online Pharmacies
Figure 11. Drug Stores
Figure 12. Global Non-invasive Insulin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Non-invasive Insulin Market Size (2019-2030) & (US$ Million)
Figure 14. Global Non-invasive Insulin Sales (2019-2030) & (K Units)
Figure 15. Global Non-invasive Insulin Average Price (US$/Unit) & (2019-2030)
Figure 16. Non-invasive Insulin Report Years Considered
Figure 17. Non-invasive Insulin Sales Share by Manufacturers in 2023
Figure 18. Global Non-invasive Insulin Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Non-invasive Insulin Players: Market Share by Revenue in Non-invasive Insulin in 2023
Figure 20. Non-invasive Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Non-invasive Insulin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Non-invasive Insulin Sales Market Share by Country (2019-2030)
Figure 23. North America Non-invasive Insulin Revenue Market Share by Country (2019-2030)
Figure 24. United States Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Non-invasive Insulin Sales Market Share by Country (2019-2030)
Figure 27. Europe Non-invasive Insulin Revenue Market Share by Country (2019-2030)
Figure 28. Germany Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Non-invasive Insulin Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Non-invasive Insulin Revenue Market Share by Region (2019-2030)
Figure 35. China Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Non-invasive Insulin Sales Market Share by Country (2019-2030)
Figure 43. Mexico Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Non-invasive Insulin Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Non-invasive Insulin Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Non-invasive Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Non-invasive Insulin by Type (2019-2030)
Figure 53. Global Revenue Market Share of Non-invasive Insulin by Type (2019-2030)
Figure 54. Global Non-invasive Insulin Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Non-invasive Insulin by Application (2019-2030)
Figure 56. Global Revenue Market Share of Non-invasive Insulin by Application (2019-2030)
Figure 57. Global Non-invasive Insulin Price (US$/Unit) by Application (2019-2030)
Figure 58. Non-invasive Insulin Value Chain
Figure 59. Non-invasive Insulin Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
